title: Methylnaltrexone (Relistor®) does not impact opioid-mediated analgesia at therapeutic doses.
authors.affiliation: Department of Anesthesia and Critical Care, The University of Chicago, 5841 S. Maryland Ave., M.C. 4028, Chicago, IL 60637, USA Salix Pharmaceuticals, Inc., Raleigh, NC, USA.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Moss
authors.forename: Craig
authors.initials: C
authors.lastname: Paterson
mesh_terms: D016058:Analgesia, Patient-Controlled; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009020:Morphine / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010149:Postoperative Pain / Q000188:drug therapy*
chemical_list: D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D009020:Morphine